ArticleIn vivo (Athens, Greece)

Long-term Survival With Afatinib in a Patient With Lung Adenocarcinoma Harboring Double Uncommon

Gen Ohara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.